| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
Mus musculus
|
Nov 01, 2022
|
|||||||
| GSM6068593 |
HC1
|
SRA |
|
1 | Ethan Bahl | Nov 01, 2022 | |||
| GSM6068594 |
HC2
|
SRA |
|
1 | Ethan Bahl | Nov 01, 2022 | |||
| GSM6068595 |
HC3
|
SRA |
|
1 | Ethan Bahl | Nov 01, 2022 | |||
| GSM6068596 |
SOR1
|
SRA |
|
1 | Ethan Bahl | Nov 01, 2022 | |||
| GSM6068597 |
SOR2
|
SRA |
|
1 | Ethan Bahl | Nov 01, 2022 | |||
| GSM6068598 |
SOR3
|
SRA |
|
1 | Ethan Bahl | Nov 01, 2022 | |||
| GSM6004960 |
NSG ID8, ABX, Placebo, Replicate 1
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004961 |
NSG ID8, H2O, Cisplatin, Replicate 1
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004962 |
NSG ID8, H2O, Cisplatin, Replicate 2
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004963 |
NSG ID8, ABX, Cisplatin, Replicate 1
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004964 |
NSG ID8, H2O, Placebo, Replicate 1
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004965 |
NSG ID8, ABX, Placebo, Replicate 2
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004966 |
NSG ID8, H2O, Cisplatin, Replicate 3
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004967 |
NSG ID8, H2O, Cisplatin, Replicate 4
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004968 |
NSG ID8, H2O, Placebo, Replicate 2
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004969 |
NSG ID8, ABX, Cisplatin, Replicate 2
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004970 |
NSG ID8, ABX, Cisplatin, Replicate 3
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004971 |
NSG ID8, ABX, Cisplatin, Replicate 4
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM6004972 |
NSG ID8, H2O, Placebo, Replicate 3
|
SRA |
|
1 | Peter Bazeley | Nov 01, 2022 | |||
| GSM5710045 |
LSCs, cxcl12_MUT10_1
|
SRA |
|
1 | Itziar Cenzano | Nov 01, 2022 |
